Sponsored by
In today’s post:
🌊 Trump Just Taxed the Ocean
💀 The Mag 7 Trade Is Dead
💔 Cathie Broke Up With Biotech
Stop googling AI tools at midnight.
There are over 3,000 of them in The Shift’s vault, already vetted, ready to explore.
Subscribe and get instant access to the tool vault, a 1000+ prompt library, and free AI courses built for people with actual work to do.
Plus, the daily newsletter that keeps you sharp on everything moving in AI in under 5 minutes a day.
They’re also giving away a free 1-year Claude Pro subscription to 3 subscribers.
Subscribe for free to enter. All free. All in one place.
🌊 Trump Just Taxed the Ocean
Trump woke up Monday and decided the Strait of Hormuz needed a landlord.
The new policy? A 20% fee on all cargo passing through the world's most important oil chokepoint. Think of it as a toll booth, except the toll booth has aircraft carriers.
His words: America is now "THE GUARDIAN OF THE HORMUZ STRAIT." Caps lock included, obviously.
Trump also announced "THE IRANIAN BLOCKADE." Iranian ships? Banned. Everyone else? Welcome aboard, please have your 20% ready.
"The Hormuz Strait is OPEN, and will remain OPEN, with or without Iran," he posted.
What’s he trying to do? The strait is open the way a nightclub is open. Depends who's on the list.
But why now?
Decades of free security, apparently. Trump told Fox News the US has been guarding the strait "for nothing" and that era is done.
"We're going to get paid for guarding it. A lot of money."
Imagine doing free overtime for 47 years and then suddenly discovering invoicing. That's the vibe.
Meanwhile, actual missiles are flying.
US forces are striking Iranian targets after Trump declared the ceasefire "over" this weekend.
The market noticed:
Oil prices jumped as the fighting resumed
Ship traffic through Hormuz hit a 5-week low
Roughly a fifth of the world's oil flows through this strait, so... yeah
The failed deal that started it all?
Trump says Iran agreed to everything after an 11-hour meeting, then called back wanting "a couple of changes."
His response: no changes. His diagnosis: Iran has been "tapping along" every US president for 47 years while getting stronger.
So instead of a deal, we got a toll booth and a blockade.
What it means for your portfolio:
Oil doesn't care about press releases. It cares about tankers. Fewer tankers moving = tighter supply = higher crude = higher prices at the pump and fatter margins for energy stocks.
If this drags on, energy is the trade everyone will claim they saw coming.
Is this genius or is this piracy?
The Ultimate Guide for Usage-Based Pricing for SaaS and AI
Implementing usage-based pricing successfully requires more than just a pricing strategy.
Download this guide for practical advice and best practices when considering usage-based pricing.
Everyone's arguing about oil prices. Warren Buffett already placed his bet.
Wall Street just flipped bullish on a stock Berkshire Hathaway has been sitting in for years, and Evercore's upgrade sent it up nearly 4% in a single session.
Here's the part most investors haven't clocked: this company's Q2 cash flow per share is on track to roughly double versus Q1. Not grow. Double.
The mechanism is almost unfair. Costs got locked in at Q1's lower prices, so nearly every extra dollar from higher oil flows straight to the bottom line.
And Buffett? He didn't deploy Berkshire capital for a polite 20% gain. Our read says the setup supports at least a double from today's price.
There's a hidden trigger too: a chunk of preferred stock that's been blocking dividends from common shareholders. The Iran situation just moved its retirement date much closer than anyone expected. When it goes, shareholder returns come flooding back.
Q2 earnings drop August 5. The institutional pile-in has started. You want to be through the door before it finishes.
In today's Premium+ deep dive, we break down:
Why the smart money entry window is closing fast (and how much room is left)
The exact cash flow math behind the "double" projection
The preferred stock domino that unlocks higher dividends
The one geopolitical wildcard that could blow up the thesis, and what to watch on August 5
💀 The Mag 7 Trade Is Dead
New Vanda Research data shows something weird happening in 2026.
Net retail inflows? Falling off a cliff. Weekly stock purchases just hit their lowest level since the Covid meltdown.
Sounds bearish, right?
Wrong.
Actual trading activity is in the 99.7th percentile. Historically. That's not "stepping away from the market." That's basically everyone at the table shuffling chips at once.
So what's going on?
Retail investors aren't selling because they're scared. They're selling because they're taking profits.
And look at what they're dumping:
Apple $AAPL ( ▼ 0.77% )
Tesla $TSLA ( ▲ 0.36% )
Nvidia $NVDA ( ▲ 4.06% )
A pile of semiconductor names
Notice a pattern? Those are the AI rally's biggest winners.
This isn't panic. It's cashing out your chips while you're still up.
Here's the bigger shift though.
The Magnificent Seven is breaking up. Not officially. But retail no longer treats it as one trade.
Investors are now picking winners and losers within the group. Buying the strong. Trimming the tired.
The "buy all seven and nap" era? Ending.
Retail hasn't gone home. It's just gone selective.
The Mag 7 rally: are you cashing out or riding it? 💰
💔 Cathie Broke Up With Biotech
Cathie Wood went shopping again. And her cart is full of rockets.
ARK Invest's biggest buy last week? Elon Musk's SpaceX.
She scooped up 349K shares across four ARK funds for ~$52.1M.
So where else did the money go?
Cathie spread the love across her favorite themes:
Eli Lilly $LLY ( ▼ 2.48% ) – $25.8M
Meta $META ( ▲ 0.66% ) – $20.7M
X-Energy $XE ( ▼ 0.65% ) – $15.4M
Coinbase $COIN ( ▲ 2.62% ) – $14.3M
Circle $CRCL ( ▲ 0.35% ) – $13.8M
AI, crypto, and futuristic medicine. The usual ARK starter pack.
She's also loading up on AI drug discovery like it's Black Friday. Ionis ($8.8M), Generate Biomedicines ($5M), Prime Medicine ($4.4M), plus top-ups in Tempus AI, Recursion, Compass Pathways, and Alamar.
The thesis? Let the robots find the cures. Buy the robots.
Crypto conviction? Still fully caffeinated.
More Coinbase. More Circle. More Bullish (yes, that's actually the ticker).
Cathie's betting the crypto rails get built whether Bitcoin has a good week or not.
She also tossed $9.1M at Kratos Defense and $2.8M at CoreWeave. Drones and AI clouds. Very 2026.
But here's the interesting part. She's dumping genomics.
The same sector she once called the future? Getting shown the door:
Natera – $18.1M sold
Illumina – $17.8M
Twist Bioscience – $15M
10X Genomics – $13.1M
BioNTech – $11.6M
Plus trims in Guardant, CareDx, Veracyte, Adaptive Bio, and more.
It's like watching someone quietly unfollow their ex. One post at a time.
Outside healthcare, she took profits too.
$33.8M of AMD $AMD ( ▲ 2.57% ) gone. $22.3M of Roku $ROKU ( ▼ 0.41% ). Smaller cuts to Robinhood, Deere, and Iridium.
Nothing personal, AMD. Just cashing some chips before earnings season.
Cathie spent July 6-10 aggressively reshuffling the deck before Q2 earnings. Out with gene sequencers, in with rockets and AI.
Classic ARK. Never boring.
Cathie just dumped biotech and bet $52M on SpaceX. Be honest, would YOU trust her with your money? 🚀